Shoulder Innovations (NYSE:SI) CEO Robert Joseph Ball Buys 6,000 Shares

Key Points

• CEO Robert Joseph Ball of Shoulder Innovations purchased 6,000 shares at an average cost of $15.49, increasing his ownership by 5.70% to a total of 111,259 shares.
• The stock of Shoulder Innovations is currently down 4.7%, trading at $14.97, with a market cap of $227.99 million and a PE ratio of -0.50.
• Analysts maintain a "Moderate Buy" rating for Shoulder Innovations, with an average target price of $19.60, supported by multiple firms giving bullish outlooks.

Shoulder Innovations, Inc. (NYSE:SI - Get Free Report) CEO Robert Joseph Ball acquired 6,000 shares of the stock in a transaction dated Friday, September 12th. The stock was bought at an average cost of $15.49 per share, with a total value of $92,940.00. Following the completion of the purchase, the chief executive officer owned 111,259 shares of the company's stock, valued at approximately $1,723,401.91. The trade was a 5.70% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Robert Joseph Ball also recently made the following trade(s):

• On Thursday, September 11th, Robert Joseph Ball acquired 2,000 shares of Shoulder Innovations stock. The stock was bought at an average cost of $14.90 per share, with a total value of $29,800.00.

Shoulder Innovations Stock Down 4.7%

Shares of Shoulder Innovations stock traded down $0.74 on Monday, hitting $14.97. The company had a trading volume of 78,248 shares, compared to its average volume of 173,990. The company has a market cap of $227.99 million and a PE ratio of -0.50. Shoulder Innovations, Inc. has a 1 year low of $11.75 and a 1 year high of $17.94.

Wall Street Analyst Weigh In

Several analysts have recently commented on the company. Morgan Stanley assumed coverage on Shoulder Innovations in a research note on Monday, August 25th. They issued an "overweight" rating and a $18.00 price objective for the company. Piper Sandler started coverage on Shoulder Innovations in a report on Monday, August 25th. They issued an "overweight" rating and a $18.00 target price for the company. Zacks Research raised Shoulder Innovations to a "hold" rating in a report on Tuesday, August 26th. Jefferies Financial Group started coverage on Shoulder Innovations in a report on Monday, August 25th. They issued a "buy" rating and a $19.00 target price for the company. Finally, BTIG Research reaffirmed a "buy" rating and issued a $23.00 target price on shares of Shoulder Innovations in a report on Tuesday, September 9th. Five research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, Shoulder Innovations currently has an average rating of "Moderate Buy" and an average target price of $19.60.

About Shoulder Innovations

We are a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. We currently offer advanced implant systems for shoulder arthroplasty. These systems are a core element of our ecosystem, which we designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.